The Fall 2020 edition of the newsletter on SWOG's Lung-MAP precision medicine trial is out. Lung-MAP is NCI's first precision trial, and tests new treatments for non-small cell cancer in partnership with the National Cancer Institute, Foundation for the National Institutes of Health, and Friends of Cancer Research.

The newsletter announces an upcoming sub-study, S1900E, and an Oct. 26 training and trial update webinar that will provide sites with details on this new treatment offering for patients. The fall newsletter also includes the latest accrual data, and gives an overview of the current open sub-studies available to patients. Read the newsletter here.

Other Recent Stories

SWOG Front Line Banner
Jun 18, 2021
Hope has issued this year's open call for strategic proposals
SWOG Front Line Banner
Jun 4, 2021
The roles of nurse scientists and advanced practice providers within SWOG have been expanding